Universidad Complutense de Madrid
E-Prints Complutense

Dental management of patients with haemophilia in the era of recombinant treatments: increased efficacy and decreased clinical risk

Impacto

Downloads

Downloads per month over past year

Liras, Antonio and Romeu, Luis (2019) Dental management of patients with haemophilia in the era of recombinant treatments: increased efficacy and decreased clinical risk. BMJ Case Reports, 12 (4). pp. 1-6. ISSN 1757-790X

[img]
Preview
PDF
Creative Commons Attribution Non-commercial.

385kB

Official URL: https://casereports.bmj.com/content/12/4/e227974.long



Abstract

Haemophilia is a hereditary X-linked recessive disorder caused by a deficiency of either clotting factor VIII (haemophilia A) or IX (haemophilia B). Conventional treatment is currently based on the use of either plasma derived or recombinant coagulation factors. This paper reports on the case of a patient with severe haemophilia who presented with mesial decay and interproximal tartar build-up, for which extraction and scaling to remove tartar deposits were indicated. Following extraction, the usual haemostasis techniques were applied, and postoperative prophylactic antihaemophilic treatment was indicated for 2 or 3 days. The patient presented with moderate bleeding for a few minutes immediately after the procedure. Administration of factor VIII before surgery as well as the patient’s favourable pharmacokinetic response allowed for an optimal result. This treatment has afforded patients with haemophilia a better quality of life, and safe and efficient access to invasive surgical procedures.


Item Type:Article
Subjects:Medical sciences > Dentistry
ID Code:57352
Deposited On:14 Oct 2019 17:39
Last Modified:14 Oct 2019 17:39

Origin of downloads

Repository Staff Only: item control page